IO Biotech, Inc. (IOBT)

IO Biotech Statistics

Total Valuation

IO Biotech has a market cap or net worth of $91.57 million. The enterprise value is $56.25 million.

Market Cap	91.57M
Enterprise Value	56.25M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

IO Biotech has 65.88 million shares outstanding. The number of shares has increased by 24.76% in one year.

Current Share Class	65.88M
Shares Outstanding	65.88M
Shares Change (YoY)	+24.76%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.36%
Owned by Institutions (%)	14.48%
Float	31.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.47
P/TBV Ratio	3.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.07.

Current Ratio	2.32
Quick Ratio	2.08
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -138.78% and return on invested capital (ROIC) is -83.55%.

Return on Equity (ROE)	-138.78%
Return on Assets (ROA)	-70.13%
Return on Invested Capital (ROIC)	-83.55%
Return on Capital Employed (ROCE)	-355.42%
Revenue Per Employee	n/a
Profits Per Employee	-$1.23M
Employee Count	80
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, IO Biotech has paid $1.17 million in taxes.

Income Tax	1.17M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.81% in the last 52 weeks. The beta is 0.37, so IO Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	+16.81%
50-Day Moving Average	1.15
200-Day Moving Average	1.02
Relative Strength Index (RSI)	56.15
Average Volume (20 Days)	215,815

Short Selling Information

The latest short interest is 108,748, so 0.17% of the outstanding shares have been sold short.

Short Interest	108,748
Short Previous Month	167,494
Short % of Shares Out	0.17%
Short % of Float	0.35%
Short Ratio (days to cover)	0.78

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-97.56M
Pretax Income	-87.64M
Net Income	-98.46M
EBITDA	-97.31M
EBIT	-97.56M
Earnings Per Share (EPS)	-$1.49

Balance Sheet

The company has $37.09 million in cash and $1.76 million in debt, giving a net cash position of $35.32 million or $0.54 per share.

Cash & Cash Equivalents	37.09M
Total Debt	1.76M
Net Cash	35.32M
Net Cash Per Share	$0.54
Equity (Book Value)	26.42M
Book Value Per Share	0.40
Working Capital	24.06M

Cash Flow

In the last 12 months, operating cash flow was -$80.49 million and capital expenditures -$61,000, giving a free cash flow of -$80.55 million.

Operating Cash Flow	-80.49M
Capital Expenditures	-61,000
Free Cash Flow	-80.55M
FCF Per Share	-$1.22

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IO Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.76%
Shareholder Yield	-24.76%
Earnings Yield	-107.51%
FCF Yield	-87.96%

Analyst Forecast

The average price target for IO Biotech is $9.33, which is 571.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.33
Price Target Difference	571.22%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1